DI
IRWD icon

Disciplined Investments’s Ironwood Pharmaceuticals IRWD Stock Holding History

Disciplined Investments’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-20
Closed -$213 – 808
2023
Q2 		$213 Sell
20
-6
-23% -$64 ﹤0.01% 1481
2023
Q1 		$274 Buy
26
+1
+4% +$11 ﹤0.01% 1422
2022
Q4 		$310 Buy
25
+6
+32% +$68 ﹤0.01% 1330
2022
Q3 		$0 Sell
19
-9
-32% -$102 ﹤0.01% 1400
2022
Q2 		$0 Buy
28
+9
+47% +$106 ﹤0.01% 1432
2022
Q1 		$0 Buy
+19
New +$218 ﹤0.01% 1471

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Disciplined Investments's IRWD Position: Q3 2023 in Review

Disciplined Investments sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2023, closing a stake of 20 shares — an estimated $213 sold.

Disciplined Investments first reported a position in IRWD in Q1 2022 and held it in 6 quarters. The position peaked at $310 in Q4 2022. 248 funds tracked by Wall St. Rank hold IRWD as of Q3 2023.

  • Disciplined Investments reported no remaining Ironwood Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Disciplined Investments sold 20 Ironwood Pharmaceuticals shares in Q3 2023, an estimated $213.
  • Disciplined Investments first reported a position in Ironwood Pharmaceuticals in Q1 2022 and held it in 6 quarters.
  • Disciplined Investments's Ironwood Pharmaceuticals position peaked at $310 in Q4 2022.
  • 248 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2023.

Based on Disciplined Investments's 13F filing for Q3 2023, filed 14 Nov 2023.